Anavex Life Sciences Corp (AVXL)

[georgejjl]

Monday 24 May and Tuesday 25 May 2021 could be MOST IMPORTANT for Anavex stockholders.

Dear Stockholder:

You are invited to attend the 2021 Annual Meeting of Stockholders of Anavex Life Sciences Corp. which will be held on Tuesday, May 25, 2021, 10:00 a.m., New York time.

ICPDMD 2021: 15. International Conference on Parkinson’s Disease and Movement Disorders May 24-25, 2021 in London, United Kingdom

https://waset.org/parkinsons-disease-and-movement-disorders-conference-in-may-2021-in-london

Dr Aarsland is Professor and the Head of Department of Old Age Psychiatry at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK. Professor Aarsland is also consultant psychiatrist at the Mental Health for Older Adults and Dementia, South London & Maudsley NHS Foundation Trust, where he leads the Parkinson Spectrum Memory Clinic. He earned medical degrees from Universities of Bochum, Germany and Oslo, Norway, with training as a specialist in psychiatry and geriatric psychiatry. He founded and still leads the nationally acclaimed Centre for Age-Related Disease at Stavanger University Hospital. He completed his PhD and became appointed Associate Professor and later Full Professor of Old Age Psychiatry at the University in Bergen, Norway. Later he became Professor at the University of Oslo, before becoming appointed as Professor of Clinical dementia research at the Alzheimer’s Disease Research Centre at the prestigious Karolinska Institute in Stockholm, Sweden. After working in Sweden for five years he moved to his current position at King’s College London. Professor Aarsland developed and led the European Consortium for dementia with Lewy bodies (DLB), with more than 25 centers across 13 European countries, with a common database of more than 1,200 DLB patients, by far the largest DLB sample in the world. He developed a Parkinson-spectrum Memory Clinic focusing on Parkinson’s disease and dementia with DLB patients. Professor Aarsland played a central role in the study and subsequent paper that lead to the licensing of rivastigmine for Parkinsonian dementia. Professor Aarsland has published more than 400 scientific papers and numerous books and served as an invited speaker at frequent psychiatric and neurological international scientific conferences.



Good luck and GOD bless,